Reuters logo
BRIEF-Novartis said to weigh sale of dermatology generics business - Bloomberg
November 1, 2017 / 10:11 AM / 20 days ago

BRIEF-Novartis said to weigh sale of dermatology generics business - Bloomberg

Nov 1 (Reuters) -

* Novartis is said to weigh sale of dermatology generics business which could fetch up to $1.5 billion - Bloomberg citing sources Source text - bloom.bg/2il88uk Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below